Notification Letter and Reply Form to Registered Shareholder
Filed with HKEX · Stock code 1011 · · 2 pages · English and Chinese
The English and Chinese versions of the Company’s Current Corporate Communications are now available on the Company’s website at www.ntpharma.com and the website of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) at www.hkexnews.hk respectively (the “Website Version”). The Company strongly recommends you to access the Website Version of the Current Corporate Communication and all fu
China NT Pharma Group Co., Ltd. on 6ix
Earlier from China NT Pharma
- 2026 Interim Report
- Voluntary announcement in relation to the application for compulsory enforcement by a wholly-owned subsidiary in respect of the shareholders' right to information of beijing kangchen biological technology co., limited
- Inside information announcement arbitration award
- Appointment of auditor
- Connected transaction in relation to loan capitalisation involving subscription of shares under Specific mandate
Later from China NT Pharma
- Notification Letter and Request Form to Non-Registered Holder
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Appointment of auditor and notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Form of proxy for use at extraordinary general meeting
Follow China NT Pharma into a list and get an email when it puts out news.
Follow China NT Pharma